The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Beyond Testicular and Prostate Cancer: Empowering Survivorship
Date
March 14, 2025
Credits
1 CH | Available until March 16, 2027
$40$40.00
Standard Price
This session explores key survivorship issues and holistic care strategies for testicular and prostate cancer patients before, during, and after treatment to enhance quality of life and optimize long-term health outcomes.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 3/16/2027.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures: There are no disclosures to declare.
Speaker Disclosures: There are no speaker disclosures to declare.
Commercial Support: No commercial support declared.
Accreditation Statement: The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome: After completing this learning activity, the participant will report the increased ability to discuss survivorship issues and holistic care strategies for patients with testicular or prostate cancer.
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
Beyond Testicular and Prostate Cancer: Empowering Survivorship
Renal cell carcinoma (RCC) is the most common type of kidney cancer, and accounts for over 90 percent of all renal malignancies. This presentation encompasses a discussion relative to the recognition and management of renal cell carcinoma…
This session provides a thorough discussion of fistula development, diagnosis, surgical repair, and recovery from surgery. This topic is relevant to both APPs who manage surgical patients and those who do not, because early diagnosis and ability to recognize the symptoms is key to successful repair…
This session provides an overview of prostate cancer treatment options, emphasizing the role of shared decision-making between patients and healthcare providers to enhance individualized care…
This session covers the basics of how to decipher the most common urologic imaging for the APP, with a focus on stones and CT imaging. Also discussed is the appropriate imaging for oncologic staging including PSMA for prostate cancer…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.